DIPNA PHARMACHEM LIMITED Share Price

Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company is primarily engaged in a single segment, which is pharmaceutical trading. Its products include aceclofenac, acetazolamide, albendazole, ambroxol hcl, amisulpride ip/bp, amoxicillin aripiprazole ip, azithromycin, cefixime, carbamezapin, calcium gluconate ip, cefadroxyl monohydrate ip/bp/ep cephalexin, clindamycin phosphate ip/bp/usp, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine hydrochloride, Bronopol, cm-1000, calcium cmc, calcium carbonate (light), calcium carbonate (oys), ceto stearyl alcohol, citric acid (anhydrous), and citric acid (monohydrate). It also provides assistance in setting up contract manufacturing compliance for regulated and semi-regulated pharmaceutical companies with all the global benchmark parameters of certificates like WHO-GMP.As of 26 May 2026, DIPNA PHARMACHEM LIMITED share price is ₹7.47. The stock opened at ₹7.98, compared to its previous close of ₹7.52. During today's trading session, DIPNA PHARMACHEM LIMITED share price moved in the range of ₹7.47 to ₹7.98, with an average price of ₹7.72 for the day. Looking at its last 52-week, the stock has touched a low of ₹7.47 and a high of ₹7.98.

The market capitalization of DIPNA PHARMACHEM LIMITED is ₹20 Crs, with a P/E ratio of 34.9 and a dividend yield of 0.00%.